1. No category

OUREXPERIENCE
IN CHILDREN.
THEEFFECT
OFHALOTHERAPY
M Simuniii2
M SuniiOmeiC,lMaiicaT,
L Kotruljos,lBobits,
ACipakGasparoviC,
ACvitkovi(RoiC,N Pustisek3,
G Gunekt,
'zChildren
clinicHelena,Zogreb;
3Klinika
za djeije bolesti,Zagreb;
4I nstitutRuderBoskovii;
sKlinikozakozneispolnebolesti,KBC,Zagreb;
6Poliklinika
za zastitudjecegrodoZagreba,Zogreb;
TNatalis
Samobor
tntnce.
sis,
naren
the
nty,
rom
lo of
vere
ties.
tion
rool
Abstract
Halotherapyis a therapymethod basedon beneficialeffectsof dry saltaerosolthat achievespositiveeffectson numerous
of
goalof thisresearch
isto monitorthe influence
systemby inhalingthe same.The
especially
on the respiratory
bodyorgans,
otitis,recurrent
secretion
atopicdermatitis,
bronchitis,
recurrent
obstructive
halotherapy
on childrenwith asthma,pollinosis,
from the mentioned
Thetwo yearstudyincluded73 children(5 months- 18years)suffering
and chronicrhinitis.
laryngitis
on humanlung
was investigated
conductedon children,the influenceof halotherapy
Alongwith the research
diseases.
and saltcabinswherethe dry saltaerosolgeneratedby
wasdonein the saltchambers
Halotherapy
fibroblastcellcultures.
showedpositiveeffectsin patientswith pulmonologyand alThehalotherapy
wasinhaledby the subjects.
saltgenerator,
from
Withinthe groupof children,suffering
anddrug prophylaxis.
seenby reducedsymptomsof the disease
lergydiseases
and
afterthe halotherapy
bronchitis7 out of 24 patientsstoppedthe drug prophylaxis
asthmaand recurrentobstructive
prophylaxis
and the
reducedthe drug
halotherapy
the symptomshaven'treturnedin the nextyear.In 9 out of 24patients,
patients,
3 of them werewithoutanysymptomsand
symptomshaven'treturnedin the nextyear.Out of total 12 pollinosis
during
respiratory
obstruction
out of these12werewithoutthe usualrecurrent
duringthe pollination.Two
drugprophylaxis
drugtherapy.
Sixout of 12patientshadminimumsymptomswith the occasional
the pollinationwith the drug prophylaxis.
At the childrenwith atopic
with the drugsand halotherapy.
Oneout of 12 patientsdid not manageto controlthe disease
(average
after
the therapyit wasfrom
halotherapy
and
of 36.74)beforethe
indexvariedfrom 20 to 61.8
dermatitisSCORAD
patients
A partof the respiratory
of the patients.
of the clinicalimprovement
21.85)whichwasthe evidence
3to 50 (average
by in vitroresultsof slightstimbestresults(strengthened
andlocaltestresults.The
of symptoms
noticedthe improvements
from
appliedat the childrensuffering
havebeennoticedon the saltconcentration
ulationof humanfibroblastproliferation)
molecular
studiesin
anddemandmoreclinicalstudiesaswellasmechanistic
asthma.All the statedresultsareencouraging
of the halotheraswellasallthe possibilities
by whichthesepositiveeffectsareachieved,
mechanisms
orderto understand
apyapplications.
lpers
!y on
nent,
h
Reference:
N6.-P.
8-15.
and Rehabilitation.,
Balneology
Diseases,
Phisiotherapy,
of Respiratory
Halotherapy
A.V.(2003),
1. Chervnskaya
8, Number3, Fall;8(3):221-32.
J.AerosolMed.Volume
diseses,
for tretmentof respiratory
A.V.,
ZilberN.A(1
995).,Halotherapy
2. Chervinskaya
52
Trialof Long-Term
In haledHypertonicSalineinPatienswith Cystic
3. ElkinsM. R.,RobinsonM.,RoseB.R.and al.A Controlled
EngfJ Med 2006;354:229-240.
W.,RomagnoliM.,Sordo1.,at al;(2003)
Hypersaline
n asalirrigation
in childrenwith symptomaticseasonal in
4. Garavello
allergicrhinitis:A randomizedstudy;
PediatrAllergy
lmmunol.2003:14:140-143
symptomaticseasonal
5. GelardiM.,Lannuzzi1.,GrecoMianiA.,Cazzanigac
5.,NaldiL.,DeLucaaC.,QuarantaN.(2013),
Double-blindplacebo-controlled
pertrophyand related.
izedclinicaltrialon the efficacyof Aerosalo
in the treatmentof subobstructive
adenotonsillarhy
1)Haloterapija
u bolestimadisnogsustavadjece nasirezultati.;
Zdravstveni
turizam:
6. GunekMatukatG.,Majica1.,BencekN.(201
je, voda,kultura,Knjigaizlaganjana znanstvenom
skupu,Klanjec.
in asthmatics;
7. HedmanJ.,HuggT.,SandellJ.(2006),
Theeffectof saltchamber
treatmenton bronchialhyperresponsiveness
605-610.
Clinicalvalidationand guidelinesfor the SCORAD
index:
8. KunzB.,OranjeA.P.,LabrEze
L.,Stalderj.F.,RingJ.,TaiebA.,(1997)
reportof the European
TaskForceon AtopicDermatitis.
Dermatology
;195:10-19.
9. MarkJ.D.,Pediatric
asthmaan integrativeapproachto careNutr.,Clin.Pract.2009
Oct-Nov;24(5):578-88.
10. Nurov1.,(2010)
lmmunologicfeaturesof speleotherapy
in patientswith chronicobstrctivepulmonarydidease;Medicaland health
Volume2, pp.44-47.
enceJournal,MHSJ,
11. European
TaskForceon AtopicDermatitis,(l993)
Severityscoringof atopicdermatitis:
the SCORAD
index.Dermatology;
186:23-31
GlobalInitiativefor Asthma(2014)A PocketGuidefor Physicians.